Experience with a 22 molecular marker predesigned tissue microarray in the preoperative setting of breast cancer treated with FEC-docetaxel, comparing complete responders with incomplete responders, and incomplete responders before and after treatment

Autor:	E. Adrover Cebrián, J. Gasent Blesa, M. Piris Pinilla, M. Rodríguez Pinilla, V. Alberola Candel, L. Sanchez Verde
Rok vydání:	2008
Předmět:	Oncology Cancer Research medicine.medical_specialty Pathology Tissue microarray business.industry medicine.disease chemistry.chemical_compound Breast cancer Docetaxel chemistry Internal medicine Molecular marker medicine business After treatment medicine.drug
Zdroj:	Journal of Clinical Oncology. 26:22151-22151
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2008.26.15_suppl.22151
Popis:	22151 Background: Studies with Tissue Microarray (TMA) technology in the preoperative setting of breast cancer have been done using thousands of genes, searching for the most relevant genes associa...
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9cbf7a9f95c949f6a78f81dae1992e2e https://doi.org/10.1200/jco.2008.26.15_suppl.22151 Zobrazit plný text záznamu